Work

Feasibility of whole-genome sequencing using cytology samples for cancer genomic analysis: a pilot study with xenograft and clinical samples

Year: 2026
Type: preprint
Abstract: Background Whole-genome sequencing (WGS) offers comprehensive genomic profiling but generally requires high-quality nucleic acids from fresh-frozen (FF) tissue. For broader application of genome-scale cancer analysis, more readily available sample types are needed. Cytology samples may provide better nucleic acid quality than formalin-fixed paraffin-embedded tissue and therefore represent a potential alternative source for WGS. We evaluated the feasibility of WGS using cytology samples by comparison with matched FF samples. Methods WGS and RNA sequencing were performed using cytology and FF tumor samples from a HER2-positive BT-474 xenograft model and a patient with endometrioid carcinoma. Concordance of SNV, CNA, and SV findings between cytology and FF samples was assessed. Results For SNVs, filtering with variant allele frequency ≧ 0.1 yielded nearly 90% concordance between patient FF and cytology samples. For CNAs, ERBB2 amplification was detected in xenograft-derived cytology samples, supporting the utility of cytology samples for copy number analysis, although no clinically relevant CNAs were identified in the clinical sample. Structural variant analysis showed limited concordance. Conclusions Cytology samples may represent a feasible alternative source for WGS-based short-variant analysis when fresh-frozen tissue is unavailable, whereas CNA and especially structural variant detection require further optimization and complementary approaches.
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W7225887593
Cites: 32
Cited by:
Related to: 10